AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

AlphaTON Capital Corp Director's Dealing 2017

May 4, 2017

34761_dirs_2017-05-03_a40d39a3-8224-4838-8fe0-4c39b19f9e32.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Biohaven Pharmaceutical Holding Co Ltd. (BHVN)
CIK: 0001689813
Period of Report: 2017-05-03

Reporting Person: PORTAGE BIOTECH INC. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	6341500	Direct